Format

Send to

Choose Destination
Autoimmun Rev. 2014 Apr-May;13(4-5):565-8. doi: 10.1016/j.autrev.2014.01.042. Epub 2014 Jan 11.

Diagnosis and classification of pernicious anemia.

Author information

1
Laboratory of Clinical Pathology, San Antonio Hospital, via Morgagni 18, 33028 Tolmezzo, UD, Italy. Electronic address: nicola.bizzaro@ass3.sanita.fvg.it.
2
Laboratory of Clinical Pathology, Civic Hospital, via Garziere 42, 36014 Santorso, VI, Italy. Electronic address: antonio.antico@ulss4.veneto.it.

Abstract

Pernicious anemia (PA) is a complex disorder consisting of hematological, gastric and immunological alterations. Diagnosis of PA relies on histologically proven atrophic body gastritis, peripheral blood examination showing megaloblastic anemia with hypersegmented neutrophils, cobalamin deficiency and antibodies to intrinsic factor and to gastric parietal cells. Anti-parietal cell antibodies are found in 90% of patients with PA, but have low specificity and are seen in atrophic gastritis without megaloblastic anemia as well as in various autoimmune disorders. Anti-intrinsic factor antibodies are less sensitive, being found in only 60% of patients with PA, but are considered highly specific for PA. The incidence of PA increases with age and is rare in persons younger than 30 years of age. The highest prevalence is seen in Northern Europeans, especially those in the United Kingdom and Scandinavia, although PA has been reported in virtually every ethnic group. Because of the complexity of the diagnosis, PA prevalence is probably underestimated and no reliable data are available on the risk of gastric cancer as the end-stage evolution of atrophic gastritis in these patients.

KEYWORDS:

Atrophic gastritis; Intrinsic factor antibodies; Megaloblastic anemia; Parietal cell antibodies; Pernicious anemia; Vitamin B(12)

PMID:
24424200
DOI:
10.1016/j.autrev.2014.01.042
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center